Clinical Trial Update: A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase I pharmacokinetics and safety study evaluating two dapivirine intravaginal gels for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dapivirine intravaginal gel (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED